Search

Your search keyword '"da Silva, Luciane Sussuchi"' showing total 26 results

Search Constraints

Start Over You searched for: Author "da Silva, Luciane Sussuchi" Remove constraint Author: "da Silva, Luciane Sussuchi" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
26 results on '"da Silva, Luciane Sussuchi"'

Search Results

1. Establishment and molecular characterization of HCB-541, a novel and aggressive human cutaneous squamous cell carcinoma cell line

2. Comprehensive microRNA expression analysis of pediatric gonadal germ cell tumors: unveiling novel biomarkers and signatures

3. Single nCounter assay for prediction of MYCN amplification and molecular classification of medulloblastomas: a multicentric study

4. Gene expression profiles (GEPs) of immuno-oncologic pathways as predictors of response to checkpoint inhibitors in advanced NSCLC

6. Validation of a 5-gene signature for predicting outcomes in early-stage NSCLC patients

7. Reproducibility of a 12-gene set for predicting outcome and benefit from ACT in early-stage NSCLC patients

9. Cell-free DNA promotes malignant transformation in non-tumor cells

10. miR‐99a‐5p as a biomarker for lymph node metastasis prediction in oral squamous cell carcinoma patients

11. PD.02.02 Lung TS: A New 6-Gene Signature for Prediction of Response to Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer Patients

12. PSP.03 12-Gene Expression Signature: A Potential Key for Predicting Prognosis and Benefit to ACT for Resectable NSCLC Patients

13. PD.02.04 A Prognostic Value of 3 Gene Sets for Ever-Smokers With Non-small Cell Lung Cancer From Brazil

14. Efficacy of Combined Use of Everolimus and Second-Generation Pan-EGRF Inhibitors in KRAS Mutant Non-Small Cell Lung Cancer Cell Lines

16. LungTS: A new gene expression signature for prediction of response to checkpoint inhibitors in non-small cell lung cancer.

17. sj-doc-5-tam-10.1177_17588359221127678 – Supplemental material for Cancer immune profiling unveils biomarkers, immunological pathways, and cell type score associated with glioblastoma patients’ survival

18. Comprehensive Molecular Landscape of Cetuximab Resistance in Head and Neck Cancer Cell Lines

19. Cancer immune profiling unveils biomarkers, immunological pathways, and cell type score associated with glioblastoma patients’ survival

20. A 4-Gene Signature Associated With Recurrence in Low- and Intermediate-Risk Endometrial Cancer

21. LungTS: A new gene expression signature for prediction of response to checkpoint inhibitors in non-small cell lung cancer

22. Abstract 2165: Reproducibility of a 12-gene panel and development of user-friendly nomogram-based calculator for clinical management of surgically resected non-small cell lung cancer patients

23. Loss of 5′-Methylthioadenosine Phosphorylase (MTAP) is Frequent in High-Grade Gliomas; Nevertheless, it is Not Associated with Higher Tumor Aggressiveness

26. Gene expression profiles (GEPs) of immuno-oncologic pathways as predictors of response to checkpoint inhibitors in advanced NSCLC

Catalog

Books, media, physical & digital resources